- Home
- GUTS vs IAE Comparison
GUTS vs IAE Comparison
Compare GUTS & IAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GUTS
- IAE
- Stock Information
- Founded
- GUTS 2010
- IAE 2007
- Country
- GUTS United States
- IAE United States
- Employees
- GUTS N/A
- IAE N/A
- Industry
- GUTS
- IAE Trusts Except Educational Religious and Charitable
- Sector
- GUTS
- IAE Finance
- Exchange
- GUTS NYSE
- IAE Nasdaq
- Market Cap
- GUTS 58.8M
- IAE 65.2M
- IPO Year
- GUTS 2024
- IAE N/A
- Fundamental
- Price
- GUTS $1.98
- IAE $6.77
- Analyst Decision
- GUTS Buy
- IAE
- Analyst Count
- GUTS 1
- IAE 0
- Target Price
- GUTS $10.00
- IAE N/A
- AVG Volume (30 Days)
- GUTS 210.4K
- IAE 46.3K
- Earning Date
- GUTS 05-13-2025
- IAE 01-01-0001
- Dividend Yield
- GUTS N/A
- IAE 10.21%
- EPS Growth
- GUTS N/A
- IAE N/A
- EPS
- GUTS N/A
- IAE N/A
- Revenue
- GUTS $60,000.00
- IAE N/A
- Revenue This Year
- GUTS N/A
- IAE N/A
- Revenue Next Year
- GUTS N/A
- IAE N/A
- P/E Ratio
- GUTS N/A
- IAE N/A
- Revenue Growth
- GUTS N/A
- IAE N/A
- 52 Week Low
- GUTS $0.87
- IAE $5.31
- 52 Week High
- GUTS $7.05
- IAE $6.45
- Technical
- Relative Strength Index (RSI)
- GUTS 60.25
- IAE 75.34
- Support Level
- GUTS $1.85
- IAE $6.62
- Resistance Level
- GUTS $2.00
- IAE $6.73
- Average True Range (ATR)
- GUTS 0.16
- IAE 0.08
- MACD
- GUTS -0.01
- IAE -0.00
- Stochastic Oscillator
- GUTS 59.82
- IAE 92.50
About GUTS FRACTYL HEALTH INC
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.